Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 10:14:10 GMT 2023
by
admin
on
Sat Dec 16 10:14:10 GMT 2023
|
Protein Type | MONOCLONAL ANTIBODY |
Protein Sub Type | IGG2A |
Sequence Origin | HUMANIZED MOUSE |
Sequence Type | COMPLETE |
Record UNII |
UMD07X179E
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QL04AB05
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
||
|
WHO-ATC |
L04AB05
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
||
|
EMA ASSESSMENT REPORTS |
CIMZIA (REFUSED: CROHN DISEASE)
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
||
|
NDF-RT |
N0000175610
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
||
|
EMA ASSESSMENT REPORTS |
CIMZIA (AUTHORIZED: ARTHRITIS, RHEUMATOID)
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Certolizumab Pegol
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
PRIMARY | |||
|
CERTOLIZUMAB PEGOL
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
PRIMARY | |||
|
100000089458
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
PRIMARY | |||
|
CHEMBL1201831
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
PRIMARY | |||
|
8448
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
PRIMARY | |||
|
428863-50-7
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
PRIMARY | |||
|
4968
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
PRIMARY | |||
|
C468008
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
PRIMARY | |||
|
SUB25423
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
PRIMARY | |||
|
DB08904
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
PRIMARY | |||
|
PP-10
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
PRIMARY | |||
|
709271
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
PRIMARY | RxNorm | ||
|
UMD07X179E
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
PRIMARY | |||
|
m3272
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
PRIMARY | Merck Index | ||
|
UMD07X179E
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
PRIMARY | |||
|
6774
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
PRIMARY | |||
|
C80972
Created by
admin on Sat Dec 16 10:14:10 GMT 2023 , Edited by admin on Sat Dec 16 10:14:10 GMT 2023
|
PRIMARY |
From | To |
---|---|
1_22 | 1_96 |
1_145 | 1_201 |
1_221 | 2_214 |
2_23 | 2_88 |
2_134 | 2_194 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Molecular Formula | CHEMICAL |
|
||||
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
Biological Half-life | PHARMACOKINETIC |
|
|
|||